Achilles therapeutics' new immunogenicity prediction application of its ai-powered peleus™ platform uniquely identifies the most potent t cell antigens

- new ai module delivers a "target-to-t cell” approach for revolutionizing the identification and prioritization of targets for personalized antigen approaches - - new ai module delivers a "target-to-t cell” approach for revolutionizing the identification and prioritization of targets for personalized antigen approaches -
ACHL Ratings Summary
ACHL Quant Ranking